Spectral AI, Inc. (NASDAQ:MDAI – Free Report) – Investment analysts at HC Wainwright lifted their FY2024 earnings per share estimates for Spectral AI in a report released on Thursday, November 7th. HC Wainwright analyst S. Ramakanth now anticipates that the company will earn ($0.46) per share for the year, up from their prior estimate of ($0.66). HC Wainwright has a “Buy” rating and a $3.50 price target on the stock. The consensus estimate for Spectral AI’s current full-year earnings is ($0.57) per share. HC Wainwright also issued estimates for Spectral AI’s Q4 2024 earnings at ($0.09) EPS, Q2 2025 earnings at ($0.15) EPS, Q3 2025 earnings at ($0.15) EPS, Q4 2025 earnings at ($0.16) EPS, FY2025 earnings at ($0.64) EPS and FY2026 earnings at $0.33 EPS.
Spectral AI (NASDAQ:MDAI – Get Free Report) last issued its quarterly earnings results on Monday, August 12th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The company had revenue of $7.48 million during the quarter, compared to analysts’ expectations of $6.00 million.
Get Our Latest Analysis on Spectral AI
Spectral AI Stock Performance
Shares of MDAI opened at $1.35 on Monday. The company has a market capitalization of $24.99 million, a P/E ratio of -2.12 and a beta of 0.48. Spectral AI has a one year low of $0.82 and a one year high of $3.72. The stock has a 50-day moving average price of $1.26 and a 200 day moving average price of $1.53.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MDAI. Virtu Financial LLC acquired a new position in Spectral AI during the 1st quarter valued at approximately $38,000. Forum Financial Management LP acquired a new position in Spectral AI during the 2nd quarter valued at approximately $51,000. Finally, Murchinson Ltd. acquired a new position in Spectral AI during the 1st quarter valued at approximately $85,000. Institutional investors and hedge funds own 67.08% of the company’s stock.
About Spectral AI
Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.
See Also
- Five stocks we like better than Spectral AI
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What is an Earnings Surprise?
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Spectral AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral AI and related companies with MarketBeat.com's FREE daily email newsletter.